04:51 PM EST, 11/06/2024 (MT Newswires) -- Natarajan Sethuraman, President, Research & Development, on November 04, 2024, sold 18,219 shares in Entrada Therapeutics ( TRDA ) for $339,281. Following the Form 4 filing with the SEC, Sethuraman has control over a total of 164,997 shares of the company, with 164,997 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1689375/000168937524000064/xslF345X05/wk-form4_1730929001.xml